Robert Schnoll

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc Is a cancer diagnosis a teachable moment for the patient's relative who smokes?
    Robert A Schnoll
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Cancer Causes Control 24:1339-46. 2013
  2. pmc Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch
    Robert A Schnoll
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Addict Dis 32:46-52. 2013
  3. pmc High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial
    Robert A Schnoll
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Nicotine Tob Res 15:348-54. 2013
  4. pmc Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation
    Robert A Schnoll
    Department of Psychiatry, Abramson Cancer Center, and Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA 19104, United States
    Addict Behav 37:565-8. 2012
  5. pmc Biomarkers to optimize the treatment of nicotine dependence
    Robert A Schnoll
    Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Presbyterian Medical Center 1 PHI, 51 N 39th Street, Philadelphia, PA 19104, USA
    Biomark Med 5:745-61. 2011
  6. pmc Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
    Addict Behav 36:144-7. 2011
  7. ncbi request reprint Smoking cessation treatment by primary care physicians: An update and call for training
    Robert A Schnoll
    Transdisciplinary Tobacco Use Research Center, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Am J Prev Med 31:233-9. 2006
  8. ncbi request reprint Current and emerging pharmacotherapies for treating tobacco dependence
    Robert A Schnoll
    Department of Psychiatry, Transdisciplinary Tobacco Use Research Center, University of Pennsylvania, 3535 Market Street, 4th Floor, Philadelphia, PA 19104, USA
    Expert Opin Emerg Drugs 11:429-44. 2006
  9. pmc Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation
    Robert A Schnoll
    Department of Psychiatry, The University of Pennsylvania, Philadelphia, PA 19104, USA
    J Subst Abuse Treat 34:234-41. 2008
  10. ncbi request reprint Genetics and smoking behavior
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Philadelphia, PA 19104, USA
    Curr Psychiatry Rep 9:349-57. 2007

Detail Information

Publications43

  1. pmc Is a cancer diagnosis a teachable moment for the patient's relative who smokes?
    Robert A Schnoll
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Cancer Causes Control 24:1339-46. 2013
    ..This study examined a cancer diagnosis, versus orthopedic surgery, as a teachable moment for recruiting smokers and treating nicotine dependence among patients' relatives...
  2. pmc Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch
    Robert A Schnoll
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Addict Dis 32:46-52. 2013
    ..This study suggests the need to examine novel psychological mechanisms that may account for the relationship between depression symptoms and smoking cessation...
  3. pmc High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial
    Robert A Schnoll
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Nicotine Tob Res 15:348-54. 2013
    ..Thus, faster metabolizers of nicotine may require a higher nicotine patch dose to achieve cessation...
  4. pmc Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation
    Robert A Schnoll
    Department of Psychiatry, Abramson Cancer Center, and Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA 19104, United States
    Addict Behav 37:565-8. 2012
    ..This study evaluated whether extended vs. standard duration treatment with nicotine patch helps those able to quit smoking to reduce cessation-induced weight gain and explored nicotine patch adherence as a mediator of treatment effects...
  5. pmc Biomarkers to optimize the treatment of nicotine dependence
    Robert A Schnoll
    Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Presbyterian Medical Center 1 PHI, 51 N 39th Street, Philadelphia, PA 19104, USA
    Biomark Med 5:745-61. 2011
    ..Barriers to the translation of this research to clinical practice are discussed, as are directions for future research...
  6. pmc Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
    Addict Behav 36:144-7. 2011
    ....
  7. ncbi request reprint Smoking cessation treatment by primary care physicians: An update and call for training
    Robert A Schnoll
    Transdisciplinary Tobacco Use Research Center, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Am J Prev Med 31:233-9. 2006
    ..Public health and government organizations have invested considerably to increase physician adherence to smoking-cessation practice guidelines...
  8. ncbi request reprint Current and emerging pharmacotherapies for treating tobacco dependence
    Robert A Schnoll
    Department of Psychiatry, Transdisciplinary Tobacco Use Research Center, University of Pennsylvania, 3535 Market Street, 4th Floor, Philadelphia, PA 19104, USA
    Expert Opin Emerg Drugs 11:429-44. 2006
    ....
  9. pmc Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation
    Robert A Schnoll
    Department of Psychiatry, The University of Pennsylvania, Philadelphia, PA 19104, USA
    J Subst Abuse Treat 34:234-41. 2008
    ..There was no evidence for mediation. In bupropion smoking cessation trials, blind failure may occur and participant guess about treatment arm assignment is associated with quit rates...
  10. ncbi request reprint Genetics and smoking behavior
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Philadelphia, PA 19104, USA
    Curr Psychiatry Rep 9:349-57. 2007
    ..As this research advances, it will be important to study and address practical, economic, ethical, and social barriers to the translation of genetics research on tobacco use to clinical practice...
  11. ncbi request reprint Treating tobacco dependence in women
    Robert A Schnoll
    The Transdisciplinary Tobacco Use Research Center, Department of Psychiatry, and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Womens Health (Larchmt) 16:1211-8. 2007
    ..Greater attention to the unique needs of female smokers may allow healthcare providers to optimize delivery of pharmacotherapy and behavioral counseling to aid their female patients to quit smoking...
  12. pmc A placebo-controlled trial of modafinil for nicotine dependence
    Robert A Schnoll
    Department of Psychiatry, Abramson Cancer Center, and Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA, United States
    Drug Alcohol Depend 98:86-93. 2008
    ..Modafinil (Provigil), a wakefulness medication shown to have efficacy for the treatment of cocaine addiction, was tested as a novel therapy for nicotine dependence in a double-blind placebo-controlled trial...
  13. pmc Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Pharmacol Biochem Behav 92:6-11. 2009
    ..38, t[355]=-3.09, p<.05). These data support the value of the 3-HC/cotinine ratio as a biomarker to predict success with transdermal nicotine for smoking cessation...
  14. doi request reprint A bupropion smoking cessation clinical trial for cancer patients
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, 4th Floor, Philadelphia, PA, 19104, USA
    Cancer Causes Control 21:811-20. 2010
    ..Many cancer patients continue to smoke post diagnosis, yet there have been few smoking cessation trials for this population. Depression, which is prevalent among cancer patients, may be a barrier to cessation...
  15. pmc Sex heterogeneity in pharmacogenetic smoking cessation clinical trials
    Robert A Schnoll
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 104:S94-9. 2009
    ..We conclude this paper with a summary and a brief discussion of the major caveats of this literature and priorities for future research...
  16. pmc Correlates of continued tobacco use and intention to quit smoking among Russian cancer patients
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, 4th Floor, Philadelphia, PA 19104, USA
    Int J Behav Med 18:325-32. 2011
    ..Little attention has been paid to tobacco use among cancer patients in developing countries, including Russia, where tobacco use is extremely high, and there is little public health infrastructure to address this issue...
  17. pmc Physician barriers to incorporating pharmacogenetic treatment strategies for nicotine dependence into clinical practice
    R A Schnoll
    Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin Pharmacol Ther 89:345-7. 2011
    ..This article describes barriers to clinical integration of pharmacogenetic treatments that will need to be addressed to realize the benefits of individualized smoking-cessation treatment...
  18. doi request reprint Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, Philadelphia, 19143, USA
    Acta Oncol 50:678-84. 2011
    ..Identifying prospective predictors of smoking cessation among patients currently receiving smoking cessation treatment can help guide the development and implementation of smoking cessation programs with this population...
  19. pmc Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, 4th Floor, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 107:237-43. 2010
    ..This study compared the effectiveness of transdermal nicotine vs. nicotine lozenge for smoking cessation and identified predictors of treatment response...
  20. doi request reprint A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, Philadelphia, 19104, USA
    Health Commun 26:735-42. 2011
    ..A larger clinical trial to evaluate a genetic prime message for improving recruitment into smoking cessation programs is warranted...
  21. pmc Translational research in nicotine dependence
    Jill R Turner
    Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Cold Spring Harb Perspect Med 3:a012153. 2013
    ..This article reviews translational studies targeting manipulations of the cholinergic system as a viable therapeutic target for nicotine addiction...
  22. pmc Correlates of smoking cessation self-efficacy in a community sample of smokers
    Elisa Martinez
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, 4th Floor, Philadelphia, PA 19104, United States
    Addict Behav 35:175-8. 2010
    ..g., during a celebration; F[7,600]=9.05, p<.05). These findings can be used to refine behavioral smoking cessation interventions to increase self-efficacy to quit smoking...
  23. pmc Genetics and smoking cessation improving outcomes in smokers at risk
    Caryn E Lerman
    Transdisciplinary Tobacco Use Research Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Am J Prev Med 33:S398-405. 2007
    ..However, additional trials including larger and more diverse populations are needed before such data can be translated to practice to reduce smoking prevalence and tobacco-related disease...
  24. ncbi request reprint Pharmacogenetics and smoking cessation with nicotine replacement therapy
    Riju Ray
    Department of Psychiatry, The Transdisciplinary Tobacco Use Research Center and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    CNS Drugs 21:525-33. 2007
    ..Larger-scale investigations that incorporate pathway-based or genome-wide analysis, as well as intermediate measures of nicotine dependence (i.e. 'endophenotypes'), may be necessary to capture the complexity of pharmacogenetic effects...
  25. ncbi request reprint Prevalence and correlates of tobacco use among Russian cancer patients: implications for the development of smoking cessation interventions at a cancer center in Russia
    Robert A Schnoll
    Fox Chase Cancer Center, Division of Population Science, Philadelphia, Pennsylvania 19012, USA
    Int J Behav Med 13:16-25. 2006
    ..In sum, this study fills a critical gap in knowledge concerning the epidemic of tobacco use in Russia and broadens research regarding tobacco use by cancer patients from the United States to the Russian Federation...
  26. doi request reprint Nicotine dependence: biology, behavior, and treatment
    Riju Ray
    Transdisciplinary Tobacco Use Research Center, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Annu Rev Med 60:247-60. 2009
    ..Enhanced understanding of these dimensions of nicotine dependence may help to advance progress toward lowering the prevalence rate of tobacco use in the U.S. and lowering the rate of tobacco-related morbidity and mortality...
  27. pmc Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104, USA
    Ann Intern Med 152:144-51. 2010
    ..Tobacco dependence is a chronic, relapsing condition that may require extended treatment...
  28. pmc Issues related to implementing a smoking cessation clinical trial for cancer patients
    Elisa Martinez
    Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Cancer Causes Control 20:97-104. 2009
    ..Recruitment strategies are needed for patients with advanced disease and specific cancers. Once enrolled, addressing participant's depressive symptoms is critical for promoting cessation...
  29. ncbi request reprint Predictors of enrollment in a smoking cessation clinical trial after eligibility screening
    Jamie Lyn Dahm
    Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Natl Med Assoc 101:450-5. 2009
    ..A fraction of smokers considered eligible for pharmacotherapy treatment trials for nicotine dependence enrolled. Little is known about smokers not enrolling in a treatment trial or how these smokers differ from those who have enrolled...
  30. ncbi request reprint Implementation of a comprehensive cancer control program at the worksite: year one summary report
    Mark J Cornfeld
    Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA
    J Occup Environ Med 44:398-406. 2002
    ..Modifiable cancer risk factors can be identified in the majority of workers. Inaccurate risk perception is an important target for future interventions...
  31. ncbi request reprint Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group
    Robert A Schnoll
    Psychosocial and Behavioral Medicine Program, Fox Chase Cancer Center, Philadelphia, PA 19012, USA
    J Clin Oncol 21:355-65. 2003
    ..Because patients have regular contact with oncologists, the efficacy of a physician-based smoking cessation treatment was evaluated...
  32. ncbi request reprint Processes of change related to smoking behavior among cancer patients
    Robert A Schnoll
    Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer Pract 10:11-9. 2002
    ..The relationship between medical variables and processes of change was also explored...
  33. ncbi request reprint Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation
    Robert A Schnoll
    Fox Chase Cancer Center, Division of Population Science, Philadelphia, Pennsylvania 19012, USA
    Int J Behav Med 13:8-15. 2006
    ..These results can be used to guide the development of smoking cessation training programs for Russian physicians...
  34. ncbi request reprint A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients
    Robert A Schnoll
    Fox Chase Cancer Center, Philadelphia, Cheltenham, Pennsylvania 19012, USA
    Ann Behav Med 30:1-11. 2005
    ....
  35. ncbi request reprint Spiral computed tomography and lung cancer: science, the media, and public opinion
    Robert A Schnoll
    Transdisciplinary Tobacco Use Research Center, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
    J Clin Oncol 25:5695-7. 2007
  36. ncbi request reprint Longitudinal predictors of continued tobacco use among patients diagnosed with cancer
    Robert A Schnoll
    Fox Chase Cancer Center, Psychological and Behavioral Medicine Program, Cheltenham, PA 19012, USA
    Ann Behav Med 25:214-22. 2003
    ..continuous smokers exhibited a significantly lower level of risk perceptions than continuous abstainers. These findings can be useful for the development and evaluation of treatments to promote smoking cessation among cancer patients...
  37. ncbi request reprint Psychological issues related to the use of spiral CT for lung cancer early detection
    Robert A Schnoll
    Psychosocial and Behavioral Medicine Program, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, PA 19012, USA
    Lung Cancer 39:315-25. 2003
    ....
  38. ncbi request reprint Correlates of tobacco use among smokers and recent quitters diagnosed with cancer
    Robert A Schnoll
    Psychosocial and Behavioral Medicine Program, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, PA 19012, USA
    Patient Educ Couns 46:137-45. 2002
    ....
  39. ncbi request reprint Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment
    Robert A Schnoll
    Division of Population Science, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, Pennsylvania 19012, USA
    Head Neck 26:278-86. 2004
    ..We examined reasons patients provide for declining smoking treatment and compared treatment decliners to enrollees...
  40. ncbi request reprint Tobacco control in the physician's office: a matter of adequate training and resources
    Robert A Schnoll
    J Natl Cancer Inst 96:573-5. 2004
  41. ncbi request reprint Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients
    Robert A Schnoll
    Division of Population Science, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, PA 19012, USA
    Psychooncology 13:346-58. 2004
    ..These findings can help guide the development of smoking cessation interventions for cancer patients...
  42. ncbi request reprint Characteristics of female smokers attending a lung cancer screening program: a pilot study with implications for program development
    Robert A Schnoll
    Psychosocial and Behavioral Medicine Program, Fox Chase Cancer Center, 510 Township Line Road, Cheltenham, PA 19012, USA
    Lung Cancer 37:257-65. 2002
    ....
  43. ncbi request reprint Change in worksite smoking behavior following cancer risk feedback: a pilot study
    Robert A Schnoll
    Division of Population Science, Fox Chase Cancer Center, Cheltenham, PA 19012, USA
    Am J Health Behav 29:215-27. 2005
    ..To pilot a worksite smoking intervention...

Research Grants13

  1. Assessment of a Teachable Moment for Smoking Cessation
    Robert A Schnoll; Fiscal Year: 2010
    ..This study could clarify the TM concept for smoking cessation, shed light on the underlying mechanisms of TMs, and guide future development and implementation of TM-based smoking cessation interventions. ..
  2. An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
    Robert Schnoll; Fiscal Year: 2009
    ..g., promotion of recovery following a lapse) for maintenance therapy with transdermal nicotine will also be assessed. The study results may change how we treat nicotine dependence with transdermal nicotine. ..
  3. Assessment of a Teachable Moment for Smoking Cessation
    Robert Schnoll; Fiscal Year: 2009
    ..This study could clarify the TM concept for smoking cessation, shed light on the underlying mechanisms of TMs, and guide future development and implementation of TM-based smoking cessation interventions. ..
  4. Assessment of a Teachable Moment for Smoking Cessation
    Robert Schnoll; Fiscal Year: 2007
    ..This study could clarify the TM concept for smoking cessation, shed light on the underlying mechanisms of TMs, and guide future development and implementation of TM-based smoking cessation interventions. ..
  5. Smoking Cessation for Head and Neck Cancer Patients
    Robert Schnoll; Fiscal Year: 2006
    ..In turn, our findings may help guide the implementation of smoking cessation treatments for all cancer patients within Comprehensive Cancer Centers in the US. ..
  6. An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
    Robert A Schnoll; Fiscal Year: 2010
    ..g., promotion of recovery following a lapse) for maintenance therapy with transdermal nicotine will also be assessed. The study results may change how we treat nicotine dependence with transdermal nicotine. ..